Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.75
Delayed Data
As of May 27
 +0.13 / +8.02%
Today’s Change
1.30
Today|||52-Week Range
5.12
-7.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line-26.8M-26.4M-30.5M-21.5M
 
 
 
 
 
Depreciation2.6M2.5M2.5M2.4M
 
 
 
 
 
Total Other Cash Flow3.0M4.0M2.7M2.7M
 
 
 
 
 
Funds From Operations-21.2M-19.9M-25.3M-16.4M
 
 
 
 
 
Funds From/For Other Operating Expenses2.7M6.4M-389.0K1.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-24.0M-26.3M-24.9M-17.6M
 
 
 
 
 
 
InvestingCapital Expenditures-700.0K-9.0M-192.0K-247.0K
 
 
 
 
 
Fixed Asset Disposal0.002.2M0.00135.0K
 
 
 
Net Cash Flow Investing-755.0K-6.8M472.0K-112.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-614.0K-645.0K-663.0K-687.0K
 
 
 
 
 
Net Proceeds Stock Sale684.0K271.0K694.0K127.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing70.0K-374.0K31.0K-560.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash368.0K-2.0M-725.0K1.6M
 
 
 
 
 
 
Net Change In Cash-24.6M-33.4M-24.4M-18.3M